Two Top Stocks to Keep an Eye on: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Avinger, Inc. (NASDAQ:AVGR)

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)

The shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) started off the last trading session with the price of $4.97 while closing the day with the price of $4.96. The shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Fell -0.4% with the Loss of -0.01 points.

The shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) traded with the day volume of 906979 shares whereas its average trading volume is 1.37 Million.

While analyzing the past performance of the stock we can see that the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Gain 1.64% in the last week while rising 15.89% in the last month. Past quarter performance shows the green light with 9.49%. The semi-annual and annual performance shows -34.39% and -8.49% respectively.

Some critical values of the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) to be discussed here are: the beta which shows the value at 2.59 while Average True Range of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) demonstrate the value at 0.24. The weekly and monthly volatility of the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) are indicated at 4.32% and 4.91%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 54.85.

While studying the financial position of the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), we can see that the Market capitalization of the company is at 586.32 Million. The shares outstanding for the company is 118.21 Million and the shares float stands at 117.6 Million. The income of the company stand at -275100000 while the sales stand at 60.6 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -2.37, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 9.68, the Return on Asset ROA stood at -1.014 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -1.901.


Avinger, Inc. (NASDAQ:AVGR)

Avinger, Inc. (NASDAQ:AVGR) started its previous trading session at $1.3 and closed at $1.29 showing a Fell of -0.77 Percent.

The Company traded with an average Volume of 327.38 Million whereas, its Day Volume stood at 670665.

Looking at the performance of the stock, Avinger, Inc. (NASDAQ:AVGR) Loss -2.27% in the last week in its shares price and -67.01% in the last month. Quarterly performance shows a red of -87.98 Percent while Semi-Annual and Annual performances shows a -89.92 and -98.43 percent respectively.

Beta for Avinger, Inc. (NASDAQ:AVGR) stands at 0 while the ATR (average true range) is at 0.45. The Stock’s Weekly and Monthly Volatility is 12.83% and 20.90% respectively showing a RSI value of 21.98.

While studying the financial position of the shares of Avinger, Inc. (NASDAQ:AVGR), we can see that the Market capitalization of the company is at 1.1 Million. The shares outstanding for the company is 850000 and the shares float stands at 790000.

The Company generated an income of -52100000 and the sales of 12.7 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-87.68 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 0.09 respectively.

The Return on Assets stands at -1.476, ROE shows a value of 3.962 and ROI for Avinger, Inc. (NASDAQ:AVGR) is -1.115 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment